Thymosin α1 is a biologically active polypeptide isolated from thymus. It is known to have immunomodulatory, antiviral, angiogenic, and wound healing effects, and has been reported to activate tumor-related macrophages. In China, subcutaneous injection of thymosin α1 is suggested to improve immunity which is considered to prevent the aggravation of coronavirus-infected persons.
By using an aqueous SEC (GFC) column, PROTEIN KW-802.5, each component in a sample containing ribonuclease, human insulin, thymosin α1 and somatostatin were separated well and they eluted in descending order of molecular weight.
Sample : 1 mg/mL each, 5 μL
1. Ribonuclease A (MW: 13,700)
2. Human insulin (MW: 5,808)
3. Thymosin α1 (MW: 3,108)
4. Somatostatin (MW: 1,521)
Column : Shodex PROTEIN KW-802.5 (8.0 mm I.D. x 300 mm) Eluent : 0.1 %(w/v) L-Arginine aq./CH3CN=550/450, pH 3.0 adjusted with TFA Flow rate : 1.0 mL/min Detector : UV (220 nm) Column temp. : 25 °C
Please select your location to continue:
For all other locations please click “close” and return to the homepage.
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve our services. If you are happy to accept these cookies please click “Accept” or simply continue to use our website. To find out more about the cookies we use, see “More Information”.